Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
GlaxoSmithKline (GSK) and Chiromics have partnered to discover classes of small molecules against biological targets. The collaboration will leverage Chiromics' compound collections of accessible complexity, Chalis, hit recognition ...
Tags: biological targets, classes of Small Molecules, drug discovery